Transforming growth factor-β1 mediates cellular response to DNA damage in situ

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5627-5631

  Ewan, Kenneth B ^a   Henshall Powell, Rhonda L ^a   Ravani, Shraddha A ^a   Pajares, Maria Jose ^a   Arteaga, Carlos ^b   Warters, Ray ^c   Akhurst, Rosemary J ^d   Barcellos Hoff, Mary Helen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FATE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; EMBRYONAL TISSUE; FEMALE; GENE ACTIVATION; GENE DOSAGE; GENE FUNCTION; IONIZING RADIATION; KNOCKOUT MOUSE; MALE; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

NASA DISCIPLINE RADIATION HEALTH; NON-NASA CENTER;

ANIMALS; APOPTOSIS; CELL CYCLE; DNA DAMAGE; EMBRYO; EPITHELIAL CELLS; FEMALE; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PREGNANCY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037108674     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Roberts, A. B., and Wakefield, L. TGF-β signaling: Positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev., 12: 22-29, 2002
2. Tang, B., Bottinger, E. P., Jakowlew, S. B., Bangall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., and Wakefield, L. M. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med., 4: 802-807, 1998
3. Massague, J., Blain, S. W., and Lo, R. S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell, 103: 295-309, 2000
4. Barcellos-Hoff, M. H., Derynck, R., Tsang, M. L-S., and Weatherbee, J. A. Transforming growth factor-β activation in irradiated murine mammary gland. J. Clin. Investig., 93: 892-899, 1994
5. Ehrhart, E. J., Carroll, A., Segarini, P., Tsang, M. L.-S., and Barcellos-Hoff, M. H. Latent transforming growth factor-β activation in situ: Quantitative and functional evidence following low dose irradiation. FASEB J., 11: 991-1002, 1997
6. Letterio, J. J., Geiser, A. G., Kulkarni, A. B., Roche, N. S., Sporn, M. B., and Roberts, A. B. Maternal rescue of transforming growth factor-β1 null mice. Science (Wash. DC), 264: 1936-1938, 1994
7. Ewan, K. B., Shyamala, G., Ravani, S. A., Tang, Y., Akhurst, R. J., Wakefield, L., and Barcellos-Hoff, M. H. Latent TGF-β activation in mammary gland: Regulation by ovarian hormones affects ductal and alveolar proliferation. Am. J. Pathol., 160: 2081-2093, 2002
8. Koli, K. M., Ramsey, T. T., Ko, Y., Dugger, T. C., Brattain, M. G., and Arteaga, C. L. Blockade of transforming growth factor-β signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells. J. Biol. Chem., 272: 8296-8302, 1997
9. Meyn, R. E., Stephens, L. C., Mason, K. A., and Medina, D. Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: Significance of gland differentiation and p53 status. Int. J. Cancer, 65: 466-472, 1996
10. Kuperwasser, C., Pinkas, J., Hurlbut, G. D., Naber, S. P., and Jerry, D. J. Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment. Cancer Res., 60: 2723-2729, 2000
11. Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., and Gudkov, A. V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy [see comments]. Science (Wash. DC), 285: 1733-1737, 1999
12. Chao, C., Saito, S., Anderson, C. W., Appella, E., and Xu, Y. Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage. Proc. Natl. Acad. Sci. USA. 97: 11936-11941, 2000
13. Derynck, R., Ackhurst, R. J., and Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet., 29: 117-129, 2001
14. Jerry, D. J., Kittrell, F. S., Kuperwasser, C., Laucirica, R., Dickinson, E. S., Bonilla, P. J., Butel, J. S., and Medina, D. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene, 19: 1052-1058, 2000
15. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991
16. Fisher, D. E. Apoptosis in cancer therapy: Crossing the threshold. Cell, 78: 539-542, 1994
17. MacCallum, D. E., Hupp, T. R., Midgley, C. A., Stuart, D., Campbell, S. J., Harper, A., Walsh, F. S., Wright, E. G., Balmain, A., Lane, D. P., and Hall, P. A., The p53 response to ionising radiation in adult and developing murine tissues. Oncogene, 13: 2575-2587, 1996
18. Hainaut, P., and Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53: 4469-4473, 1993
19. Barcellos-Hoff, M. H., and Dix, T. A. Redox-mediated activation of latent transforming growth factor-β1. Mol. Endocrinol., 10: 1077-1083, 1996
20. Appella, E., and Anderson, C. W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem., 268: 2764-2772, 2001
21. 1 arrest, p53, and Rb. Cancer Res., 56: 3645-3650, 1996
22. Ohmori, T., Yang, J. L., Price, J. O., and Arteaga, C. L. Blockade of tumor cell transforming growth factor-βs enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy. Exp. Cell Res., 245: 350-359, 1998
23. 6-methylguanine methyltransferase promoter hypermethylation. J. Biol. Chem., 276: 19052-19058, 2001
24. Teramoto, T., Kiss, A., and Thorgeirsson, S. S. Induction of p53 and Bax during TGF-β1 initiated apoptosis in rat liver epithelial cells. Biochem. Biophys. Res. Commun., 251: 56-60, 1998
25. Merryman, J. I., Neilsen, N., and Stanton, D. D. Transforming growth factor-β enhances the ultraviolet-mediated stress response in p53-/- keratinocytes. Int. J. Oncol., 13: 781-789, 1998
26. Wakefield, L. M., Yang, Y., and Dukhanina, O. TGF-β and breast cancer: Lessons learned from genetically altered mouse models. Breast Cancer Res., 2: 100-106, 2000
27. Reiss, M., and Barcellos-Hoff, M. H. Transforming growth factor-β in breast cancer: A working hypothesis. Br. Cancer Res. Treat., 45: 81-95, 1997